Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis, backache, toothache, cold and fever. It is also used in the management of severe pain such as post-surgical and cancer pain. It operates a single-location manufacturing facility on the Tarapur industrial estate.

Employees

Sector

Specialty Chemicals

More about the company

Quotes

Date	Price	Change	Volume
18/09/26	₹123.26	+0.42%	155,553
17/09/26	₹122.75	+5.00%	67,876
16/09/26	₹116.91	-4.66%	111,457
15/09/26	₹122.63	-4.13%	104,961
11/09/26	₹127.91	+2.49%	234,978

End-of-day quote NSE India S.E.

More quotes

End-of-day quote NSE India S.E. 18/09/2026			5-day change	1st Jan Change
123.26 ^INR	+0.42%		-3.64%	+76.09%

08-10	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-10	Valiant Laboratories Limited Approves the Opening of New Corporate Office	CI

Market Cap	6.69B 69.77M 60.84M 57.44M 52.16M 97.73M 98.14M 688M 266M 3.4B 262M 256M 10.95B	P/E 2025	-150x	P/E 2026	-79.4x
Enterprise Value	6.83B 71.13M 62.02M 58.57M 53.18M 99.64M 100M 702M 271M 3.47B 267M 261M 11.17B	EV / Sales 2025	2.83x	EV / Sales 2026	1.24x
Free-Float	23.22%	Yield 2025 *	-	Yield 2026	-

Markets		Quality
NSE India S.E.	VALIANTLAB	End-of-day quote
Bombay S.E.	VALIANTLAB	Delayed

08-10	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-10	Valiant Laboratories Limited Approves the Opening of New Corporate Office	CI
05-20	Valiant Organics Limited agreed to acquire 34.26% stake in Valiant Laboratories Limited from Dhanvallabh Ventures LLP.	CI
05-14	Valiant Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-23	Valiant Laboratories Limited Announces Resignation of Bhanudas D. Patil as Q.C Manager, Senior Management Personnel, Effective April 22, 2026	CI
02-11	Valiant Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
01-15	Valiant Laboratories Ltd receives notice for total tax demand of approx. 125.3 million rupees	RE
11-11	Valiant Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-07	Valiant Laboratories Arm Begins Commercial Operations at New Unit in Gujarat, India; Shares Up 4%	MT
25/09/25	Valiant Laboratories Limited Approves Change in Designation of Paresh Shah from Executive Director to Whole-Time Director, Effective September 25, 2025	CI
08/08/25	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
16/07/25	Valiant Laboratories Gets Board Nod for INR815 Million Rights Issue; Shares Up 4%	MT
15/07/25	Valiant Laboratories says rights issue price set at 75 rupees per share, entitlement ratio 1:4	RE

Valiant Laboratories Limited Stock

Stocks

VALIANTLAB

INE0JWS01017

Specialty Chemicals

Valuation: Valiant Laboratories Limited

Chart: Valiant Laboratories Limited

Latest news: Valiant Laboratories Limited

Quotes and Performance

Price Extremes

Managers and Directors: Valiant Laboratories Limited

Other Specialty Chemicals

Financials

Company Profile

Quotes

1 day	+0.42%
1 week	-3.64%
Current month	+27.94%
1 month	+34.04%
3 months	+81.53%
6 months	+122.93%
Current year	+76.09%

1 week	111.25	129.5
1 month	90.94	129.9
Current year	49.51	129.9
1 year	49.51	129.9
3 years	49.51	214.95
5 years	49.51	214.95
10 years	49.51	214.95

Manager	Title	Age	Since
Santosh Vora CEO	Chief Executive Officer	32	21/08/2021
Paresh Shah DFI	Director of Finance/CFO	66	16/08/2021
Akshay Dnyaneshwar Gangurde CMP	Compliance Officer	-	09/07/2025

Director	Title	Age	Since
Santosh Vora BRD	Director/Board Member	32	21/08/2021
Sonal Amit Vira BRD	Director/Board Member	43	16/02/2022
Paresh Shah BRD	Director/Board Member	66	16/08/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VALIANT LABORATORIES LIMITED	+0.42%	-3.64%	+41.24%	-	69.77M
ECOLAB INC.	-0.82%	-2.43%	+1.50%	+52.83%	75.54B
GIVAUDAN SA	-0.64%	+2.69%	-1.99%	+14.77%	36.43B
SIKA AG	-1.22%	-1.38%	+1.36%	-23.69%	35.55B
FUJIFILM HOLDINGS CORPORATION	-0.51%	+3.07%	-6.47%	+9.43%	25.32B
EMS-CHEMIE HOLDING AG	-1.36%	+0.38%	+38.24%	+25.04%	22.7B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-5.68%	-3.09%	+55.79%	+12.92%	19.34B
DUPONT DE NEMOURS, INC.	+0.43%	+1.59%	-44.94%	-42.25%	17.42B
NITTO DENKO CORPORATION	-0.68%	+5.52%	-0.97%	+66.44%	14.31B
SYMRISE AG	-1.20%	+2.09%	+17.56%	-0.04%	13.96B
Average	-1.13%	+0.69%	+10.13%	+12.83%	26.06B
Weighted average by Cap.	-1.16%	+0.26%	+5.08%	+19.02%

	2025	2026
Net sales	1.33B 13.9M 12.12M 11.45M 10.39M 19.47M 19.55M 137M 52.91M 678M 52.22M 51.06M 2.18B	2.37B 24.75M 21.58M 20.38M 18.5M 34.67M 34.81M 244M 94.19M 1.21B 92.97M 90.9M 3.88B
Net income	-22.01M -229K -200K -189K -172K -321K -323K -2.26M -873K -11.19M -862K -843K -36.01M	-32.68M -341K -297K -280K -255K -477K -479K -3.36M -1.3M -16.61M -1.28M -1.25M -53.46M
Net Debt	453M 4.72M 4.12M 3.89M 3.53M 6.61M 6.64M 46.55M 17.96M 230M 17.73M 17.34M 741M	131M 1.36M 1.19M 1.12M 1.02M 1.91M 1.91M 13.43M 5.18M 66.41M 5.11M 5M 214M